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Abstract
Molluscum contagiosum virus (MCV) is a common cause of benign skin lesions in young children and currently the only endemic 
human poxvirus. Following the infection of primary keratinocytes in the epidermis, MCV induces the proliferation of infected 
cells and this results in the production of wart- like growths. Full productive infection is observed only after the infected cells 
differentiate. During this prolonged replication cycle the virus must avoid elimination by the host immune system. We there-
fore sought to investigate the function of the two major histocompatibility complex class- I- related genes encoded by the MCV 
genes mc033 and mc080. Following insertion into a replication- deficient adenovirus vector, codon- optimized versions of mc033 
and mc080 were expressed as endoglycosidase- sensitive glycoproteins that localized primarily in the endoplasmic reticulum. 
MC080, but not MC033, downregulated cell- surface expression of endogenous classical human leucocyte antigen (HLA) class I 
and non- classical HLA- E by a transporter associated with antigen processing (TAP)- independent mechanism. MC080 exhibited 
a capacity to inhibit or activate NK cells in autologous assays in a donor- specific manner. MC080 consistently inhibited antigen- 
specific T cells being activated by peptide- pulsed targets. We therefore propose that MC080 acts to promote evasion of HLA- I- 
restricted cytotoxic T cells.
InTRoduCTIon
Molluscum contagiosum virus (MCV), a member of the 
genus Molluscipoxvirus, exclusively infects humans and is 
currently the only endemic human poxvirus [1]. MCV is a 
dermatotropic poxvirus that infects and induces hyperprolif-
eration of epidermal cells, yet productive infection is realized 
only following keratinocyte differentiation and culminates in 
the release of mature virions at the tip of skin papules [2, 3]. 
While the MCV replication cycle is distinct from that of other 
characterized poxviruses, the transformation of keratinocytes 
has parallels with that of the papillomaviruses. Highly conta-
gious, self- limiting MCV infections are primarily observed in 
children and can persist for months to years. The generally 
benign nature of skin lesions combined with their remarkable 
capacity to persist implies that MCV is extremely well adapted 
to its host. Spontaneous regression follows the induction of 
an inflammatory response that is characterized by the recruit-
ment of natural killer (NK) cells, T cells and dendritic cells 
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to skin lesions [4]. Serious persistent MCV infections with 
larger and more extensive lesions are indicative of an under-
lying immunodeficiency and are a recognized complication 
in severely immunocompromised human immunodeficiency 
virus - Acquired Immune Deficiency Syndrome patients [5].
The ~190 kb linear double- stranded DNA MCV genome is 
predicted to encode some 182 canonical protein- coding genes, 
including 105 that have homologues in Orthopoxviruses and 
36 that share homology with cellular genes [6, 7]. Poxviruses 
apportion much of their coding capacity to provide for an 
arsenal of intrinsic, innate and adaptive immune evasion func-
tions [8]. Although studies of MCV pathogenesis have been 
frustrated by its host restriction and the lack of a system to 
propagate the virus in vitro, the examination of MCV genes in 
isolation has revealed that MC054 sequesters interleukin-18, 
MC148 is a chemokine antagonist capable of suppressing 
chemotaxis and MC159 inhibits Tumour Necrosis Factor- 
induced NF-κB activation [9, 10].
Cytotoxic T lymphocytes (CTL) and NK cells have both been 
implicated in the effective control of poxvirus infections [11]. 
However, viruses have evolved a wide range of mechanisms 
to evade both CD8+ T cells and NK cells. Cowpox actively 
downregulates expression of the major histocompatibility 
complex 1 (MHC- I) proteins from the cell surface through 
a combination of the CPXV203 protein retaining MHC- I in 
the endoplasmic reticulum (ER) and CPXV12 preventing 
peptide loading [12–15]. In vaccinia virus (VACV) the 
host- cell shut- off function suppresses expression of both 
endogenous classical MHC- I and the non- classical human 
leukocyte antigen class- I antigen alpha chain E (HLA- E). 
In addition to their primary function of presenting peptide 
antigens to CD8+ T cells, MHC- I provide the chief ligands 
recognized by NK- cell inhibitory receptors; in main these 
include leukocyte immunoglobulin- like receptor 1 (LILRB1/
CD85J/ILT2) and killer- cell immunoglobulin- like receptors 
(KIRs). Consequently, the suppression of endogenous MHC- I 
expression has the potential to render cells more vulnerable 
to NK- cell attack. HLA- E binds a restricted set of peptides 
normally derived in a TAP- dependent manner from the leader 
sequences of classical HLA- I molecules. HLA- E is a ligand for 
the NK- cell inhibitory receptor CD94/natural killer group 2 
(NKG2)A. Loss of HLA- E from the surface renders VACV- 
infected cells more sensitive to CD94/NKG2A+ NK cells [16]. 
Moreover, the VACV haemagglutinin acts directly as a ligand 
for NK- cell activating receptors NKp30 and NKp46, yet the 
interaction with NKp30 is associated with NK- cell suppres-
sion [17].
Two human cytomegalovirus (HCMV) MHC- I homologues 
(UL18 and UL142) are well established NK- cell evasion func-
tions, with gpUL18 binding LIR1 as a MHC- I mimic [18, 19]. 
Interestingly, cowpox and monkeypox viruses also encode 
a secreted MHC class- I- like protein (OMCP) that binds 
the NK- cell- activating receptor NKG2D with high affinity, 
allowing OMCP to act as an efficient antagonist of NKG2D 
[20, 21]. The MCV genome has also been shown to encode 
two ORFs with sequence similarity to MHC- I: mc033 and 
mc080 [6]. We were interested in exploring the possibility that 
these MCV MHC- I- related genes could play a role in evasion 
of NK cells. MC033 was originally identified as having greatest 
sequence similarity to Xenopus MHC- I [7]. The protein data-
base has expanded over time and currently MC033 exhibits the 
closest similarity to a zinc- alpha-2- glycoprotein- like sequence 
present in Vombatus ursinus (common wombat). Although 
the Zinc- alpha-2- glycoprotein (ZAG) itself has a similar 
structure to MHC- I, it is a secreted protein known to stimu-
late lipid metabolism [22]. The sequence alignment between 
MC033 and MHC- like proteins in the database is restricted to 
~115 amino acids near the C- terminus of MC033. In contrast, 
the similarity between MC080 and mammalian MHC- I heavy 
chains extends through the α1, α2 and α3 domains. When 
MC080 was expressed using a replication- competent vaccinia 
virus vector the protein was observed to accumulate in the 
ER and form a complex with ß−2 microglobulin, however 
its sequence was not thought to be compatible with peptide 
binding [23]. In a study undertaken in parallel with the one 
reported here, Harvey and co- workers recently reported that 
MC080 interacts with tapasin to impair cell- surface expres-
sion of MHC- I antigen [24].
In order to investigate whether the MCV MHC- I- like genes 
modulated NK- cell function, we expressed codon- optimized 
versions of MC033 and MC080 by using a replication- deficient 
adenovirus (RAd) vector. Ectopic expression of MCO33 had 
no overt impact on NK- or T- cell function, while MC080 
was observed to both modify recognition by NK cells and to 
promote CD8+ T- cell evasion. Detailed investigation revealed 
MC080 downregulated cell- surface expression of both HLA- I 
and HLA- E.
RESuLTS
Characterizing MC033 and MC080 expression
The native forms of the mc033 and mc080 genes were synthe-
sized in extremely low amounts and induced significant cyto-
toxicity when produced using mammalian expression vectors 
[25]. It is possible these issues may be related to the high GC 
content (63%) of MCV DNA. Codon- optimized versions 
of mc033 and mc080 genes were therefore synthesized and 
inserted into a RAd to generate RAd- mc033 and RAd- mc080. 
A C- terminal V5 epitope tag was included in each construct 
to track expression. The codon- optimized versions expressed 
efficiently and with minimal cytotoxicity following infec-
tion with the RAd recombinants. MC033 and MC080 were 
observed to co- localize with an ER- marker (calnexin), but 
to be relatively distinct from the Golgi apparatus marker 
(giantin), thus both MCV proteins traffic to the ER when 
expressed in isolation (Fig. 1).
When RAd- mc033 and RAd- mc080 infected cells were 
analysed in Western blots, MC033 and MC080 were both 
expressed at peak levels by 72 h p.i. and at higher levels 
than a V5 epitope- tagged HCMV gpUS6 control (Fig. 2a). 
US6 encodes an ER resident glycoprotein that suppresses 
cell- surface HLA- I antigen presentation by inhibiting TAP 
[26]. The sensitivity of HCMV gpUS6 to endoglycosidase H 
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(EndoH) is consistent with its retention in the ER (Fig. 2b). 
MC033 was produced as a 62 kDa glycoprotein and was 
susceptible to both EndoH and Peptide:N- glycosidase 
F (PNGase) digestion (Fig.  2b). Three closely migrating 
forms of MC080 were discernible with molecular masses 
calculated at 40, 42 and 46 kDa. The 46 kDa form must be 
glycosylated as it was sensitive to both EndoH and PNGase, 
whereas the 40 kDa species may be an immature unglyco-
sylated precursor as it was unaffected by either glycosidase 
and co- migrated close to deglycosylated MC080. The 42 kDa 
form detected after PNGase treatment must also be degly-
cosylated and may be a product of differential cleavage at 
the N- terminus or some other form of post- translational 
processing. The sensitivity of MCV MC033 and MC080 
glycoforms to EndoH was compatible with the immu-
nofluorescence data that showed both proteins localized 
predominantly to the ER.
Impact of MC033 and MC080 on nK cells
We sought to investigate whether the MCV MHC- I- like 
genes were also capable of modulating NK- cell function. 
Peripheral blood mononuclear cells (PBMC) isolated from 
healthy volunteer donors were stimulated with interferon-α 
and deployed in a NK degranulation assay. A standard human 
foetal foreskin fibroblast line (HF- CAR) served as allogeneic 
targets whereas fibroblasts cultured from donor skin biopsies 
permitted NK- cell function to be assessed in an autologous 
setting. The HCMV NK- cell evasion gene UL141 [27], 
included as a positive control, inhibited NK- cell activation 
in all experiments (Fig. 3). MC033 expression in HF- CAR 
had no obvious effect on NK- cell activation in donors 008 and 
009, the elevated level observed in autologous skin fibroblasts 
with donor 009 did not reach statistical significance (Fig. 3) 
and further studies were unable to detect any effect of MC033 
on NK- cell activation (not shown). The situation with MC080 
Fig. 1. MC033 and MC080 localize to the ER. Immunofluorescence was performed on HF- CAR fibroblasts infected with RAd- mc033 or 
RAd- mc080 for 48 h (m.o.i.=5 p.f.u./cell). Expression of MC033 and MC088 was detected using an antibody to the C- terminal V5 epitope 
tag. Antibodies to calnexin and Giantin were used as ER and cis- Golgi apparatus markers (red) whilst DAPI provides a nuclear stain (blue) 
on the merged images. Results were consistent across two experiments.
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was more complex. When HF- CARs were used as targets, 
MC080 had no significant impact on donors 007, 008 or 009 
NK- cell function; the reduced level of NK- cell activation 
with donors 007 and 008 did not reach statistical signifi-
cance (Fig. 3). In an autologous setting, however, MC080 was 
observed to be capable of both activating (donor 007 and 008) 
or inhibiting NK- cell degranulation (donor 009) (Fig. 3). Thus 
MC080 was capable of modulating NK- cell function, either 
suppressing or activating the response depending on proper-
ties inherent in the effector and target cells.
HCMV UL142, a MHC- I homologue, has been reported to 
downregulate the full- length allelic forms of the NKG2D 
ligand MHC class I polypeptide- related sequence A (MICA) 
yet not the C- terminally truncated MICA*008 variant 
[28, 29]. We hypothesized that our results could be explained 
if MC080 exhibited a similar selective interaction with full- 
length and truncated MICA*008 alleles. HLA and NK- cell 
receptor genotypes for the donors and cells used in this study 
are detailed in Table S1 (available in the online version of this 
article). Remarkably, MICA genotyping revealed that donors 
007, 008 and 009 were homozygous for the same truncated 
MICA*008 allele (specifically MICA*00801/04) whereas 
HF- CARs possess full- length MICA alleles (MICA*016 and 
MICA*027). Moreover, MC080 was not able to suppress cell- 
surface expression of either the truncated MICA*008 or full- 
length MICA*027 when expressed in CHO cells, although we 
cannot exclude the possibility that such an MC080 function 
could require a species- specific factor (Fig. 4a). The differen-
tial donor- specific effect of MC080 on NK- cell responses is 
thus unlikely to operate through MICA.
Endogenous HLA- I molecules provide the chief ligands for a 
range of NK- cell inhibitory receptors that include the family 
of KIRs, LIR1 and CD94/NKG2A. However, certain HLA- I 
molecules can also be recognized by activating KIRs. The 
balance of signals to NK cells through KIR/HLA- I interaction 
will naturally be different between donors. A comparison of 
the KIR genotypes revealed that D007 and D008 are homozy-
gotic for the KIR A haplotype whereas D009 carries a KIR A 
and a KIR B (adding extra activating receptors) haplotype 
(Table S1). D007 and D008 possess an additional copy of the 
Fig. 2. MC033 and MC080 protein expression. Samples prepared from RAd- mc033, RAd- mc080, RAd- US6 and RAd- control infected HF- 
CAR (m.o.i.=5) were analysed by Western blot. Expression of the viral proteins was detected by means of a C- terminal V5 epitope tag. 
(a) The time course illustrates stronger expression of MC033 and MC080 from 48 to 72 h p.i. than the positive control HCMV gpUS6. (b) 
Cell extracts from 72 h p.i. were treated with EndoH or PNGase. The expression of endogenous HLA- I expression was assessed using the 
HC10 antibody with actin detection serving as a loading control. Results were consistent across two experiments.
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inhibitory KIR3DL1 allele, when compared to D009. D009 
possesses three activating KIRs (3DS1, 2DS1 and 2DS5) and 
one inhibitory KIR (2DL5) that are not present in D007 or 
D008. On balance, the KIR repertoire of D009 is more acti-
vating than that of D007 or D008. We therefore speculate that 
the capacity of MC080 to either suppress or activate NK- cell 
recognition depends on properties bestowed by a combina-
tion of donor and target cells and could be brought about by 
modulating HLA- I expression.
MC080 downregulates expression of HLA-I
HLA- I expression on human fibroblasts infected with RAd- 
mc080, RAd- mc033 and RAd- US6 was analysed by flow 
cytometry. MCV MC080 and HCMV gpUS6 reduced the 
levels of surface HLA- I surface expression, whereas the effect 
of expressing MC033 was comparable to the vector control 
(Fig. 4b). MC080 was also found to have a marked effect on 
total cell expression of endogenous HLA- I in Western- blot 
experiments (Fig.  2b). Not only were the levels of HLA- I 
heavy chain (HC) markedly reduced in cells expressing 
MC080, the HC was rendered susceptible to Endo- H diges-
tion thus implying it was being retained in the ER. HCMV 
US6, an inhibitor of TAP [26], and MC080 both had a similar 
effect on HLA- I whereas MC033 had no obvious effect on 
cell- surface HLA- I expression or its susceptibility of HLA- I 
to Endo- H digestion.
HLA- E is a non- classical HLA- I molecule that modulates 
NK- cell function through its interactions with the inhibi-
tory receptor CD94/NKG2A and the activating receptor 
CD94/NKG2C. Interestingly MC080 and gpUS6, but not 
MC033, also downregulated cell- surface expression HLA- E 
(Fig. 4b). HLA- E binds a highly restricted set of peptides 
that are normally derived from the signal peptide of classical 
Fig. 3. MC080 modulates NK- cell activity. The effect of MC080 and MC033 on NK- cell degranulation was assessed by measuring the 
proportion of CD107a+ cells within the CD3-CD56+ population. HF- CARs and autologous skin fibroblasts cells (D007- SFi, D008- SFi or 
D009- SFi) were infected at a m.o.i. of 5 or 500, respectively, with RAd- mc080, RAd- mc033, RAd- UL141 or the vector (RAd- control) for 
72 h. The higher m.o.i. is required to provide for comparable infection and transgene expression in the primary skin fibroblasts that 
exhibit minimal Ad receptor (hCAR) expression. Infected cells were incubated with donor PBMC with PBMC:target ratio of 10 : 1. NK- cell 
degranulation was assessed by measuring %CD107a+ cells within a CD3-CD56+ gated population within the lymphocyte gate. Results 
(shown as mean+sem) were analysed by two- way ANOVA with Tukey’s multiple comparison test; *P<0.05, ***P<0.001, ****P<0.0001. Data 
from three of four experiments in three donors shown.
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HLA- I molecules. Cell- surface expression of HLA- E is TAP- 
dependent and thus inhibited by US6 [30]. It was possible that 
MC080 could also be suppressing HLA- I and HLA- E cell- 
surface expression by targeting TAP. A TAP2 deficiency in 
the NPi fibroblast cell line is responsible for low level surface 
HLA- I and HLA- E expression [31]. However, the HLA- A*02 
allelic group is remarkable in binding hydrophobic peptides 
that enter the ER independently of TAP [32]. When an adeno-
virus encoding HLA- A2 was introduced in to NPi cells, the 
cell- surface HLA- A2 expression realized in the TAP- deficient 
cells proved to be resistant to gpUS6 yet sensitive to MC080 
(Fig. 4c). MC080 is therefore able to suppress cell- surface 
HLA- A2 in human cells lacking TAP2.
MC080 expression in target cells inhibits T-cell 
activation
To study the effect of MC080 on CD8+ T cells, CD107a assays 
were performed to measure effector cell degranulation when 
exposed to different targets. Since a tractable MCV system 
was not available, two HCMV HLA- A*0201- restricted T- cell 
lines were used, one specific for the IE1 epitope VLEETSVML 
(VLE) and a second for the pp65 epitope NLVPMVATV 
(NLV). The T- cell lines were tested in an autologous setting 
by using human epidermal fibroblasts cultured from a skin 
biopsy. MC033 exerted no significant effect on T- cell function 
(Fig. 5). While MC080 induced clear protection against T- cell 
degranulation induced by the VLE peptide, this protection 
could be overcome by increasing the peptide concentration 
(Fig.  5b). In contrast, MC080- induced protection against 
T- cell activation by the NLV peptide operated across a wide 
range of peptide concentrations (Fig.  5). The capacity of 
increasing peptide to rescue activation at the concentrations 
tested in only one of the T- cell lines may reflect differences 
in the affinity of the TCRs for their cognate peptide/HLA- I 
complex. MC080 expression thereby bestowed protection 
against T- cell activation in functional assays.
dISCuSSIon
In the absence of an in vitro system for propagating MCV, 
the two MCV MHC- I- like genes were expressed using a RAd 
vector. When cloned as their native gene sequences, both 
genes expressed extremely inefficiently and induced overt 
cytotoxicity. It is possible that the high GC content of MCV 
DNA may have caused issues in the mammalian vectors as 
the issue was overcome when their codon usage was opti-
mized. Both MC033 and MC080 were synthesized as EndoH- 
sensitive glycoproteins that localized to the ER. While MC033 
aligns with a MHC- I- like protein, the sequence similarity 
is low and restricted. MC033 lacks homology through the 
MHC- I α1 and α2 domains responsible for peptide binding 
and required for many MHC- I receptor interactions. The 
inability of MC033 to impact NK- cell function in our assays 
is consistent with it not acting as a simple MHC- I mimic.
MC080 is an EndoH sensitive, ER- associated glycoprotein 
that downregulates expression of endogenous HLA- I and 
HLA- E. MC080 was able to suppress cell- surface expression 
Fig. 4. MC080 suppresses cell- surface expression of HLA- I and HLA- E. 
Flow cytometric analysis was performed to investigate the effect 
of MC080 on MICA, HLA- E and HLA- I. (a) CHO cells were co- infected 
with RAd- mc080 and an RAd vector encoding MICA, either MICA*027 
or MICA*008 alleles, or the vector (RAd- control) for 72 h. Each virus 
was used at a m.o.i.=50 p.f.u./cell and cells stained with phycoerythrin 
(PE) conjugated anti- MICA or a PE conjugated isotype control antibody. 
(b) Cell- surface HLA- I and HLA- E were measured in HF- CAR cells 
infected with RAd- mc033, RAd- mc080, RAd- US6 or a vector control 
(m.o.i.=5 p.f.u./cell) for 72 h. (c) NPi cells, which have a defect in the TAP 
transporter, were infected with Rad- HLA- A2 together with RAd- control, 
RAd- US6 or RAd- mc080. Each virus was used at a m.o.i.=500 p.f.u./cell 
and cells stained with allophycocyanin (APC) conjugated anti- MHC- I or 
an APC- conjugated isotype control antibody. Results were consistent 
across four experiments.
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of classical HLA- I molecules and HLA- E in both TAP- positive 
and TAP- negative human cells. Moreover, post- translation 
maturation of HLA- I in the Golgi apparatus was suppressed 
by MC080. These findings implied that MC080 may be acting 
in the ER by direct sequestration or through competition 
for a factor required for HLA- I maturation. Further insight 
comes from a recent study that identifies an interaction 
between MC080 and tapasin as being critical in suppressing 
MHC- I maturation in murine cells [24]. Our observation that 
MC080 suppressed surface expression of HLA- A2.1 in TAP2- 
deficient human fibroblasts (Fig. 4) would be consistent with 
this model if tapasin retained a substantial role in loading 
TAP- independent peptides on to HLA- A2 in TAP- negative 
fibroblasts. Alternatively, MC080 may possess an additional 
mechanism for promoting MHC- I retention in human cells.
The targeting of HLA- E appears counterintuitive since it is 
recognized by the NK- cell inhibitory receptor CD94/NKG2A. 
Indeed, the downregulation of HLA- E by VACV proved 
sufficient to render infected cells sensitive to NKG2A+ NK 
cells [16]. Moreover, the upregulation of HLA- E cell- surface 
expression mediated by HCMV UL40 bestows protection 
against NKG2A+ NK cells [31, 33]. However, HLA- E can also 
be recognized by the paired NK activating receptor CD94/
NKG2C and by HLA- E- specific T cells; expansions of CD94/
NKG2C+ NK cells are commonly associated with HCMV 
infection [34–37]. A change in the target cell from allogeneic 
HF- CARs to autologous skin fibroblasts had a dramatic effect 
on NK- cell recognition (Fig. 3). Since HLA- E exhibits only 
limited sequence variation, it seemed unlikely the differential 
effects produced by MC080 expression on NK cells can be 
attributed to regulation of HLA- E.
In downregulating endogenous HLA- I, MC080 removes the 
natural ligand for multiple inhibitory or activating KIRs. 
The downregulation of a ligand for an inhibitory KIR would 
be expected to stimulate NK- cell function, as observed in 
an autologous setting for donor 007 and donor 008, whilst 
removal of the ligand for an activating ligand could result in 
NK- cell suppression, as observed in an autologous setting for 
donor 009. Donor 009 possessed a high number of activating 
KIRs (Table S1). The result illustrates the value in performing 
human NK assays in an autologous setting and revealed, in 
at least one individual, MHC- I downregulation by MC080 
Fig. 5. MC080 suppresses T- cell activation. Donor 007 (D007)- SFi were infected with RAds encoding mc080 (RAd- mc080), mc033 (RAd- 
mc033), HCMV US6 (RAdUS6) or the same vector without a transgene (RAd- control). Cells were harvested 72 h p.i. and coated with 
various concentrations of the HCMV IE1 VLE peptide (0.04 µg ml−1, 0.2 µg ml−1, 1.0 µg ml−1) to act as targets in a CD107a degranulation 
assay with a D007 HCMV VLE- specific CTL line as effectors. (a) Flow cytometric histograms showing CD107a degranulaton at 0.04ug 
ml-1 peptide coating. (b) Graph depicting CD107a degranulation over a range of peptide concentrations. One of two experiments shown. 
(c) D007- SFi cells were infected with the RAds indicated (72 h) then coated with HCMV pp65 NLV peptide (0.008 µg ml−1, 0.04 µg ml−1, 
0.2 µg ml−1, 1.0 µg ml−1). A CD107a degranulation assay was performed using a D007 HCMV NLV- specific T- cell line as effectors. HCMV 
US6, a TAP inhibitor, was included as an HLA- I downregulating control. Results (shown as mean±sd of quadruplicates) were analysed by 
two- way ANOVA with Tukey’s multiple comparison test, ****P<0.0001.
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could be associated with reduced NK- cell activation. As many 
viruses suppress endogenous MHC- I, it will be interesting to 
study further exactly how KIR usage impacts sensitivity to 
virus infection.
MCV is remarkable in being able to sustain a persistent 
infection for many months with efficient virus production 
from overt lesions in immunocompetent individuals. MC033 
and MC080 currently exhibit the closest sequence similarity 
with the common wombat ZAG and wild boar (Sus scrofa) 
MHC- I, respectively. The fact that MC080 and MC033 do not 
align closely with a human MHC- I implies there has been an 
evolutionarily complex route from host capture to the MCV 
genome. The ancient nature of their gene capture is further 
supported by the identification of homologues to both mc033 
and mc080 in the recently characterized equine molluscum 
contagiosum- like virus (Ehmann et al., in press) [38]. While 
the function of MC033 has still to be defined, the modula-
tion of endogenous HLA- I expression by MC080 is associated 
both with the evasion of MHC- I restricted cytotoxic T cells 
and modulating NK- cell activation.
METHodS
Ethics statement
Written informed consent was obtained from healthy adult 
volunteers who kindly provided blood and dermal fibroblasts 
using procedures approved by the Cardiff University School 
of Medicine Research Ethics Committee Ref. no: 10/20 and 
16/52.
Cell lines
HF- CAR cells are human foetal foreskin fibroblasts trans-
duced with retroviral vectors encoding the Coxsackie- 
adenovirus receptor and human telomerase [39]; dermal 
fibroblasts were cultured directly from skin biopsies. NPi 
cells are human fibroblasts with a genetic defect in TAP2, 
kindly provided by Professor Vincenzo Cerundolo (Univer-
sity of Oxford, UK). Chinese hamster ovary (CHO) cells 
were a kind gift of Dr Alan Parker (Cardiff University, 
UK). RAd vectors were cultured in 293- TREx cells [40]. 
All cells were grown in Dulbecco’s modified Eagle’s medium 
(DMEM) 10 % foetal calf serum (FCS) supplemented with 
penicillin/streptomycin (Invitrogen, Paisley, UK) except 
for HCMV- specific T- cell lines, which were expanded 
by co- culture with irradiated peptide- coated autologous 
fibroblasts in RPMI medium (10 % FCS, 2 % human AB 
serum, and 10 IU ml−1 interleukin-2). Primary NK cells 
were cultured as described previously [18, 36].
Viruses
Codon- optimized versions of mc033 and mc080 (Figs S1 
and S2) were produced by gene synthesis (Eurofins MWG 
Operon, Ebersberg, Germany) and amplified by PCR 
using primers containing arms of homology to permit 
direct insertion into the AdZ BAC vector (pAL1141) by 
DNA recombineering [40]. RAd- US6 and RAd- UL141 
contain HCMV US6 and UL141 respectively and have 
been described previously [41, 42]. The MICA*027 and 
MICA*008 genes cloned into the RAd vector were obtained 
from Professor Dan Davis (University of Manchester, UK) 
and Professor Paul Lehner (University of Cambridge, UK), 
respectively. The titres of Ad vectors and recombinants 
were determined by plaque assay on 293- TREx cells. The 
infection efficiency of HF- CARs and 293- TREx cells with 
RAd vectors is identical. However, primary skin fibroblasts 
have minimal hCAR expression, and needed to be infected 
with 500 p.f.u. (evaluated in permissive 293 TREx cells) per 
cell to achieve efficient transgene delivery and expression 
in all cells.
Western blot
EndoH and PNGase were used according to the manufac-
turer’s instructions (New England Biolabs, Hitchin, UK). 
Murine monoclonal antibodies were used to detect human 
HLA- I heavy chain (HC10 hybridoma kindly provided 
by Professor Hidde Ploegh, Boston Children’s Hospital, 
USA) and the V5- tag (MCA1360, cloneSV5- Pk1, BioRad, 
Watford, UK) while rabbit polyclonal antibody specific for 
actin (A2066, Sigma- Aldritch, Gillingham, UK) was used 
to check sample loading. Western blots were performed as 
described previously [27].
Flow cytometry on adherent cells
Fibroblasts or CHO cells were removed from monolayers 
using trypsin and resuspended in PBS. Anti- MHC- I- 
allophycocyanin (APC) (clone W6/32; Biolegend, London, 
UK) or anti- HLA- E- phycoerythrin (PE) (clone 3D12; Biole-
gend) were incubated with the cells (30 min at 4 °C). Mouse 
IgG2a- APC (clone MOPC-173; Biolegend) and IgG1a- PE 
(clone MOPC-21; BD Biosciences, Oxford, UK) were used 
as isotype controls for HLA- I and HLA- E, respectively. 
Cells were then washed and fixed in 2 % paraformaldehyde 
(PFA) for 10 min and analysed using an Accuri C6 flow 
cytometer (BD Biosciences, Oxford, UK).
Immunofluorescence staining and analysis
Immunofluorescence was performed as described previ-
ously [25, 43]. Cells were stained with rabbit anti- V5- tag (ab 
9116, Abcam, Cambridge, UK), mouse anti- calnexin (clone 
C8.B6, Merck Millipore, Watford, UK), polyclonal goat anti- 
mouse Alexa Fluor 594 (Invitrogen) and goat anti- rabbit 
Alexa Fluor 488 (Invitrogen), anti- Giantin polyclonal sera 
(ab24586, Abcam), 0.5 µg ml−1 4,6- diamidino-2- phenylindole 
dihydrochloride (DAPI) (Thermo Fisher), polyclonal goat 
anti- rabbit Alexa Fluor 594 (Invitrogen), and polyclonal goat 
anti- mouse- Alexa Fluor 488 (Invitrogen) as indicated and 
visualized using a Zeiss Axiomat fluorescence microscope 
(Carl Zeiss Microscopy, Germany).
nK degranulation assays
NK degranulation assays were performed as described previ-
ously [18, 41]. Briefly, 5×105 PBMC stimulated overnight 
with interferon-α (1000 IU ml−1) were incubated in triplicate 
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with 5×104 fibroblast targets and fluorescein isothiocyanate 
(FITC)- conjugated anti- CD107a mAb (clone H4A3, BD 
Biosciences) or mIgG1κ-FITC isotype isotype control (BD 
Biosciences). GolgiStop (BD Biosciences) was added after 1 h 
of incubation and the cells were incubated for a further 4 h. 
Cultures were washed with cold phosphate buffered saline 
(PBS), and stained with anti- CD3 PE- cyanine7 (clone 17A2, 
Biolegend) and anti- CD56 PE (clone N901, Beckman Coulter, 
High Wycombe, UK) mAbs for 30 min at 4 °C. Cells were 
washed twice in cold PBS, fixed in 2 % PFA and analysed using 
an Accuri C6 flow cytometer (BD Biosciences).
T-cell assays
Autologous human fibroblast targets were coated with the 
indicated concentrations of the HLA- A2 restricted IE1 
peptide VLEETSVML (VLE) or pp65 peptide NLVPM-
VATV (NLV) in 1 ml RPMI 10 % FCS for 1 h at 37 °C and 
washed twice with RPMI 10 % FCS to remove excess peptide. 
Peptide specific CD8+ T cells (105) were incubated for 5 h 
with targets (104 fibroblasts) in quadruplicate in the presence 
of FITC- conjugated anti- CD107a mAb (BD Biosciences). 
GolgiStop was added after 1 h of incubation. Cultures were 
washed with cold PBS, and stained with anti- CD3- peridinin- 
chlorophyll- protein- cyanine5.5 (clone SK7; BD Biosciences) 
and anti- CD8- APC (Biolegend) mAbs for 30 min at 4 °C. 
mIgG1κ-FITC (BD Biosciences) was used as an isotype 
control. Cells were washed twice in cold PBS, fixed in 2 % 
PFA and analysed using an Accuri C6 flow cytometer (BD 
Biosciences) [36].
KIR genotyping
KIR copy number was determined using a multiplexed real- 
time PCR method as described previously [44]. KIR alleles 
were genotyped by Next Generation Sequencing based on 
amplification of exons 3, 4, 5, 7, 8 and 9 of all KIR genes as 
described previously [45].
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